{"content":"<li class=\"n-box-item date-title\" data-end=\"1364443199\" data-start=\"1364356800\" data-txt=\"Friday, December 20, 2019\">Wednesday, March 27, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"914011\" data-ts=\"1364430604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMTOY\" target=\"_blank\">MMTOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/914011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitsubishi Motors (OTC:MMTOY -3.9%) slips in local trade after earlier reporting two malfunction...</a></h4>Mitsubishi Motors (<a href='https://seekingalpha.com/symbol/MMTOY' title='Mitsubishi Motors ADR'>OTC:MMTOY</a> <font color=\"red\">-3.9%</font>) slips in local trade after <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/912641\">earlier reporting</a> two malfunction incidents with batteries made in a joint venture with GS Yuasa (<a href='https://seekingalpha.com/symbol/GYUAF' title='Gs Yuasa Corp.'>OTCPK:GYUAF</a>) - whose shares currently remain untraded.<div class=\"tiny-share-widget\" data-id=\"914011\" data-linked=\"Mitsubishi Motors (OTC:MMTOY -3.9%) slips in local trade after earlier reporting two malfunction...\" data-tweet=\"$MMTOY $MMTOY $GYUAF - Mitsubishi Motors (OTC:MMTOY -3.9%) slips in local trade after earlier reporting two malfunction incidents with batteries made in a joint venture with GS Yuasa (OTCPK:GYUAF) - whose shares currently remain untraded. https://seekingalpha.com/news/914011?source=tweet\" data-url=\"https://seekingalpha.com/news/914011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913971\" data-ts=\"1364428702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEA\" target=\"_blank\">ATEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Astea International (OTC:ATEA) moves high in the post session despite reporting a decline in Q4...</a></h4><p>Astea International (<a href=\"https://seekingalpha.com/symbol/ATEA\" title=\"Astea International, Inc.\">OTC:ATEA</a>) moves high in the post session despite reporting a decline in <a href=\"https://seekingalpha.com/market_currents/post/913491\" target=\"_blank\">Q4 sales</a> to $6.5M, compared to $6.9M for the same period in 2011. The company blames the shortfall on lower service and maintenance revenues. Net income rose however, to $582K or $.16 per share, compared to $480K or $.13 per share for the same period in 2011. The company also commented that it expects overall progress and growth for 2013, with several new products releases planned. Shares <font color=\"green\">+15%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"913971\" data-linked=\"Astea International (OTC:ATEA) moves high in the post session despite reporting a decline in Q4...\" data-tweet=\"$ATEA - Astea International (OTC:ATEA) moves high in the post session despite reporting a decline in Q4 sales to $6.5M, compared to $6.9M for the same period in 2011. The company blames the shortfall on lower service and maintenance revenues. Net income... https://seekingalpha.com/news/913971?source=tweet\" data-url=\"https://seekingalpha.com/news/913971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913901\" data-ts=\"1364422380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array Biopharma (NASDAQ:ARRY) says it&#39;s entered into a sales agreement for an at-the-market...</a></h4>Array Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) says it's entered into a <a href=\"http://www.streetinsider.com/Equity+Offerings/Array+Biopharma+%28ARRY%29+Falls+after+%2475M+ATM+Offering+of+Stock/8216257.html\" target=\"_blank\">sales agreement</a> for an at-the-market share offering with Cantor Fitzgerald. Subject to the terms and conditions, <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>] may from time to time issue and sell through Cantor up to $75M in stock. Shares <font color=\"red\">-5%</font> AH.<div class=\"tiny-share-widget\" data-id=\"913901\" data-linked=\"Array Biopharma (NASDAQ:ARRY) says it&#39;s entered into a sales agreement for an at-the-market...\" data-tweet=\"$ARRY - Array Biopharma (NASDAQ:ARRY) says it&#39;s entered into a sales agreement for an at-the-market share offering with Cantor Fitzgerald. Subject to the terms and conditions, ARRY] may from time to time issue and sell through Cantor up to $75M in stock... https://seekingalpha.com/news/913901?source=tweet\" data-url=\"https://seekingalpha.com/news/913901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913861\" data-ts=\"1364421457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne (NASDAQ:XONE): Q4 net income of $902K. Revenue of $12.7M beats by $0.4M. Shares +4.9% AH. (PR)</a></h4><b>ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>):</b> Q4 net income of $902K. Revenue of $12.7M <font color=\"green\">beats by $0.4M</font>. Shares  <font color=\"green\">+4.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"913861\" data-linked=\"ExOne (NASDAQ:XONE): Q4 net income of $902K. Revenue of $12.7M beats by $0.4M. Shares +4.9% AH. (PR)\" data-tweet=\"$XONE - ExOne (NASDAQ:XONE): Q4 net income of $902K. Revenue of $12.7M beats by $0.4M. Shares +4.9% AH. (PR) https://seekingalpha.com/news/913861?source=tweet\" data-url=\"https://seekingalpha.com/news/913861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913821\" data-ts=\"1364420943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: GBX +3%. GNW +3%. LCC +3%. MATX +1.4%. SU +1.1%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/LCC' title=''>LCC</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/MATX' title='Matson, Inc.'>MATX</a> <font color=\"green\">+1.4%</font>. <a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color=\"green\">+1.1%</font>. <br /> <b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/ESI-OLD' title='ITT Educational Services Inc.'>ESI-OLD</a> <font color=\"red\">-6%</font>. <a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color=\"red\">-5%</font>.<div class=\"tiny-share-widget\" data-id=\"913821\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: GBX +3%. GNW +3%. LCC +3%. MATX +1.4%. SU +1.1%....\" data-tweet=\"$GBX $GBX $GNW - After-hours top gainers, as of 5:15 p.m.: GBX +3%. GNW +3%. LCC +3%. MATX +1.4%. SU +1.1%. After-hours top losers: ARRY -12%. RHT -9%. FIVE -7%. ESI-OLD -6%. PVH -5%. https://seekingalpha.com/news/913821?source=tweet\" data-url=\"https://seekingalpha.com/news/913821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913791\" data-ts=\"1364420594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on PVH (NYSE:PVH): Q4 beats on both EPS and revenue, driven by higher profit across...</a></h4><p>More on PVH (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>): <a href=\"https://seekingalpha.com/market_currents/post/913671\" target=\"_blank\">Q4 beats</a> on both EPS and revenue, driven by higher profit across virtually all its business lines. The stock is down in the post-session however, as the company issues mixed guidance for the coming year and current quarter. For 2013, it now projects revenue to be about $8.2B and EPS at $7 per share. The Street is at $7.66B in revenue and earnings of $7.42 per share. For Q1, the company is looking for an EPS of  $1.33 versus analysts estimates for $1.52, on sales of $1.90B versus the $1.85B Street estimate. Shares <font color=\"red\">-4.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"913791\" data-linked=\"More on PVH (NYSE:PVH): Q4 beats on both EPS and revenue, driven by higher profit across...\" data-tweet=\"$PVH - More on PVH (NYSE:PVH): Q4 beats on both EPS and revenue, driven by higher profit across virtually all its business lines. The stock is down in the post-session however, as the company issues mixed guidance for the coming year and current quarter... https://seekingalpha.com/news/913791?source=tweet\" data-url=\"https://seekingalpha.com/news/913791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913701\" data-ts=\"1364418795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCS\" target=\"_blank\">SCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Steelcase (NYSE:SCS): Q4 beats slightly on the revenue side, but net earnings swung to a...</a></h4><p>More on Steelcase (NYSE:<a href=\"https://seekingalpha.com/symbol/SCS\" title=\"Steelcase Inc.\">SCS</a>): <a href=\"https://seekingalpha.com/market_currents/post/913401\" target=\"_blank\">Q4 beats</a> slightly on the revenue side, but net earnings swung to a fiscal fourth-quarter loss as impairment charges and restructuring costs weighed on results. The company also guides lower for its Q1, now anticipating an EPS of $0.09 to $0.13 on revenue of $ 680M to $705M. Analysts were projecting $0.18 on $711M in revenue. Shares <font color=\"red\">-3.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"913701\" data-linked=\"More on Steelcase (NYSE:SCS): Q4 beats slightly on the revenue side, but net earnings swung to a...\" data-tweet=\"$SCS - More on Steelcase (NYSE:SCS): Q4 beats slightly on the revenue side, but net earnings swung to a fiscal fourth-quarter loss as impairment charges and restructuring costs weighed on results. The company also guides lower for its Q1, now anticipati... https://seekingalpha.com/news/913701?source=tweet\" data-url=\"https://seekingalpha.com/news/913701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913691\" data-ts=\"1364418697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913691\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A U.S. bankruptcy judge signs off on US Airways&#39; (LCC) merger with American Airlines (AAMRQ.PK)....</a></h4><p>A U.S. bankruptcy judge <a href=\"http://www.bloomberg.com/news/2013-03-27/amr-s-merger-with-us-airways-approved-by-judge-in-n-y-.html\" target=\"_blank\">signs off</a> on US Airways' (<a href=\"https://seekingalpha.com/symbol/LCC\" title=\"\">LCC</a>) merger with American Airlines (AAMRQ.PK). Approval was <a href=\"https://seekingalpha.com/currents/post/912941\" target=\"_blank\">widely expected</a>, but US Airways is still <font color=\"green\">up 2.4%</font> AH. AMR creditors holding $1.2B in claims are already backing the deal.</p><div class=\"tiny-share-widget\" data-id=\"913691\" data-linked=\"A U.S. bankruptcy judge signs off on US Airways&#39; (LCC) merger with American Airlines (AAMRQ.PK)....\" data-tweet=\"$AAL - A U.S. bankruptcy judge signs off on US Airways&#39; (LCC) merger with American Airlines (AAMRQ.PK). Approval was widely expected, but US Airways is still up 2.4% AH. AMR creditors holding $1.2B in claims are already backing the deal. https://seekingalpha.com/news/913691?source=tweet\" data-url=\"https://seekingalpha.com/news/913691\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913671\" data-ts=\"1364418557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PVH (NYSE:PVH): Q4 EPS of $1.60 beats by $0.10. Revenue of $1.64B beats by $0.04B. Shares -5.2%...</a></h4><b>PVH (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>):</b> Q4 EPS of $1.60 <font color=\"green\">beats by $0.10</font>. Revenue of $1.64B <font color=\"green\">beats by $0.04B</font>. Shares  <font color=\"red\">-5.2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"913671\" data-linked=\"PVH (NYSE:PVH): Q4 EPS of $1.60 beats by $0.10. Revenue of $1.64B beats by $0.04B. Shares -5.2%...\" data-tweet=\"$PVH - PVH (NYSE:PVH): Q4 EPS of $1.60 beats by $0.10. Revenue of $1.64B beats by $0.04B. Shares -5.2% AH. (PR) https://seekingalpha.com/news/913671?source=tweet\" data-url=\"https://seekingalpha.com/news/913671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913541\" data-ts=\"1364416419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q4 EPS of -$0.59. Shares +5.4% AH. (PR)</a></h4><b>Cyclacel Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a>):</b> Q4 EPS of -$0.59. Shares  <font color=\"green\">+5.4%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"913541\" data-linked=\"Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q4 EPS of -$0.59. Shares +5.4% AH. (PR)\" data-tweet=\"$CYCC - Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q4 EPS of -$0.59. Shares +5.4% AH. (PR) https://seekingalpha.com/news/913541?source=tweet\" data-url=\"https://seekingalpha.com/news/913541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913531\" data-ts=\"1364416398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera Pharmaceuticals (OTC:ANTH) says it&#39;s initiated Phase 3 studies of blisibimod, for the...</a></h4><p>Anthera Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ANTH\" title=\"Anthera Pharmaceuticals, Inc.\">OTC:ANTH</a>) says it's initiated Phase 3 studies of blisibimod, for the treatment of systemic lupus erythematosus. Lupus is a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain and major organ complications. Shares <font color=\"red\">-1.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"913531\" data-linked=\"Anthera Pharmaceuticals (OTC:ANTH) says it&#39;s initiated Phase 3 studies of blisibimod, for the...\" data-tweet=\"$ANTH - Anthera Pharmaceuticals (OTC:ANTH) says it&#39;s initiated Phase 3 studies of blisibimod, for the treatment of systemic lupus erythematosus. Lupus is a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain and major ... https://seekingalpha.com/news/913531?source=tweet\" data-url=\"https://seekingalpha.com/news/913531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913501\" data-ts=\"1364415998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Much like they did last week following Oracle&#39;s FQ3 miss, some enterprise IT names are selling...</a></h4><p>Much like they did <a href=\"https://seekingalpha.com/currents/post/900601\" target=\"_blank\">last week</a> following Oracle's FQ3 miss, some enterprise IT names are selling off AH following Red Hat's <a href=\"https://seekingalpha.com/currents/post/913361\" target=\"_blank\">FQ4 revenue miss</a>, which was <a href=\"https://seekingalpha.com/currents/post/913451\" target=\"_blank\">accompanied</a> by slowing deferred revenue growth. <a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a> <font color=\"red\">-2%</font>. <a href=\"https://seekingalpha.com/symbol/VMW\" title=\"VMware, Inc.\">VMW</a> <font color=\"red\">-1.9%</font>. <a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"red\">-1.1%</font>. <a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"red\">-2.1%</font>.</p><div class=\"tiny-share-widget\" data-id=\"913501\" data-linked=\"Much like they did last week following Oracle&#39;s FQ3 miss, some enterprise IT names are selling...\" data-tweet=\"$CTXS $CTXS $VMW - Much like they did last week following Oracle&#39;s FQ3 miss, some enterprise IT names are selling off AH following Red Hat&#39;s FQ4 revenue miss, which was accompanied by slowing deferred revenue growth. CTXS -2%. VMW -1.9%. FFIV -1.1%. RVB... https://seekingalpha.com/news/913501?source=tweet\" data-url=\"https://seekingalpha.com/news/913501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913491\" data-ts=\"1364415904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEA\" target=\"_blank\">ATEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Astea International (OTC:ATEA): Q4 EPS of $0.16. Revenue of $6.5M. Shares +15.2% AH. (PR)</a></h4><b>Astea International (<a href=\"https://seekingalpha.com/symbol/ATEA\" title=\"Astea International, Inc.\">OTC:ATEA</a>):</b> Q4 EPS of $0.16. Revenue of $6.5M. Shares  <font color=\"green\">+15.2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"913491\" data-linked=\"Astea International (OTC:ATEA): Q4 EPS of $0.16. Revenue of $6.5M. Shares +15.2% AH. (PR)\" data-tweet=\"$ATEA - Astea International (OTC:ATEA): Q4 EPS of $0.16. Revenue of $6.5M. Shares +15.2% AH. (PR) https://seekingalpha.com/news/913491?source=tweet\" data-url=\"https://seekingalpha.com/news/913491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913471\" data-ts=\"1364415766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLT\" target=\"_blank\">WLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walter Energy (NYSE:WLT) says it will curtail production at its Willow Creek mine in British...</a></h4><p>Walter Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/WLT\" title=\"Walter Energy, Inc.\">WLT</a>) says it will curtail production at its Willow Creek mine in British Columbia, resulting in 250 job losses out of 350 workers employed there. Willow Creek is the fifth mine WLT has announced plans to curtail or idle as part of its initiatives to address underperforming assets. Shares <font color=\"red\">-1.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"913471\" data-linked=\"Walter Energy (NYSE:WLT) says it will curtail production at its Willow Creek mine in British...\" data-tweet=\"$WLT - Walter Energy (NYSE:WLT) says it will curtail production at its Willow Creek mine in British Columbia, resulting in 250 job losses out of 350 workers employed there. Willow Creek is the fifth mine WLT has announced plans to curtail or idle as par... https://seekingalpha.com/news/913471?source=tweet\" data-url=\"https://seekingalpha.com/news/913471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913411\" data-ts=\"1364415156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Teva (TEVA -1.2%) close lower today on the back of Biogen&#39;s (BIIB +3%) earlier...</a></h4><p>Shares of Teva (<a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a> <font color=\"red\">-1.2%</font>) close lower today on the back of Biogen's (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+3%</font>) <a href=\"https://seekingalpha.com/market_currents/post/913301\" target=\"_blank\">earlier announcement</a> of FDA approval for its MS capsule Tecfidera. Earlier in the week, <a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a> had announced <a href=\"https://seekingalpha.com/market_currents/post/901681\" target=\"_blank\">its own successful results</a> from Phase III testing for its Multiple Sclerosis drug Laquinimod.</p><div class=\"tiny-share-widget\" data-id=\"913411\" data-linked=\"Shares of Teva (TEVA -1.2%) close lower today on the back of Biogen&#39;s (BIIB +3%) earlier...\" data-tweet=\"$TEVA $TEVA $BIIB - Shares of Teva (TEVA -1.2%) close lower today on the back of Biogen&#39;s (BIIB +3%) earlier announcement of FDA approval for its MS capsule Tecfidera. Earlier in the week, TEVA had announced its own successful results from Phase III tes... https://seekingalpha.com/news/913411?source=tweet\" data-url=\"https://seekingalpha.com/news/913411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913361\" data-ts=\"1364414835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat (NYSE:RHT): Q4 EPS of $0.36 beats by $0.06. Revenue of $348M (+17% Y/Y) misses by $1.6M....</a></h4><b>Red Hat (NYSE:<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a>):</b> Q4 EPS of $0.36 <font color=\"green\">beats by $0.06</font>. Revenue of $348M (+17% Y/Y) <font color=\"red\">misses by $1.6M</font>. Shares  <font color=\"red\">-6.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"913361\" data-linked=\"Red Hat (NYSE:RHT): Q4 EPS of $0.36 beats by $0.06. Revenue of $348M (+17% Y/Y) misses by $1.6M....\" data-tweet=\"$RHT - Red Hat (NYSE:RHT): Q4 EPS of $0.36 beats by $0.06. Revenue of $348M (+17% Y/Y) misses by $1.6M. Shares -6.9% AH. (PR) https://seekingalpha.com/news/913361?source=tweet\" data-url=\"https://seekingalpha.com/news/913361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913321\" data-ts=\"1364414341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASH\" target=\"_blank\">ASH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies cuts its 2013 and 2014 earnings outlook on Ashland (ASH -3%), citing weaker end-market...</a></h4><p>Jefferies <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3451095/update-jefferies-lowers-pt-on-ashland-on-weaker-end-mark\" target=\"_blank\">cuts its 2013 and 2014 earnings outlook</a> on Ashland (<a href=\"https://seekingalpha.com/symbol/ASH\" title=\"Ashland Inc.\">ASH</a> <font color=\"red\">-3%</font>), citing weaker end-market demand prospects that could affect growth and the timing of any divestitures. Deutsche Bank says ASH's expected FQ2 earnings shortfall has eroded investor goodwill, proving the business \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3450512/update-deutsche-bank-lowers-pt-on-ashland-on-fq2-shortfa\" target=\"_blank\">less resilient than we thought</a>.\" Both firms maintained Buy ratings but cut price targets.</p><div class=\"tiny-share-widget\" data-id=\"913321\" data-linked=\"Jefferies cuts its 2013 and 2014 earnings outlook on Ashland (ASH -3%), citing weaker end-market...\" data-tweet=\"$ASH - Jefferies cuts its 2013 and 2014 earnings outlook on Ashland (ASH -3%), citing weaker end-market demand prospects that could affect growth and the timing of any divestitures. Deutsche Bank says ASH&#39;s expected FQ2 earnings shortfall has eroded inv... https://seekingalpha.com/news/913321?source=tweet\" data-url=\"https://seekingalpha.com/news/913321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913301\" data-ts=\"1364413250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen Idec (BIIB +3.5%) wins FDA approval for its Tecfidera capsules, a treatment for adults...</a></h4><p>Biogen Idec (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+3.5%</font>) wins <a href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345528.htm\" target=\"_blank\">FDA approval</a> for its Tecfidera capsules, a treatment for adults with relapsing forms of multiple sclerosis.</p><div class=\"tiny-share-widget\" data-id=\"913301\" data-linked=\"Biogen Idec (BIIB +3.5%) wins FDA approval for its Tecfidera capsules, a treatment for adults...\" data-tweet=\"$BIIB - Biogen Idec (BIIB +3.5%) wins FDA approval for its Tecfidera capsules, a treatment for adults with relapsing forms of multiple sclerosis. https://seekingalpha.com/news/913301?source=tweet\" data-url=\"https://seekingalpha.com/news/913301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913211\" data-ts=\"1364410975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon (LULU -0.9%) says it won&#39;t require customers to prove that yoga pants purchased from...</a></h4><p>Lululemon (<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"red\">-0.9%</font>) says it <a href=\"http://hosted.ap.org/dynamic/stories/U/US_LULULEMON_YOGA_PANTS?SITE=AP&amp;SECTION=HOME&amp;TEMPLATE=DEFAULT&amp;CTIME=2013-03-27-14-39-57\" target=\"_blank\">won't require</a> customers to prove that yoga pants purchased from the retailer are too sheer before issuing a refund. Yesterday, a solitary report cropped up indicating a customer demonstration was required. Shares of LULU are down about ~12% since the issue with the black luon pants was first revealed - roughly the same percentage the product makes up of total sales for the company.</p><div class=\"tiny-share-widget\" data-id=\"913211\" data-linked=\"Lululemon (LULU -0.9%) says it won&#39;t require customers to prove that yoga pants purchased from...\" data-tweet=\"$LULU - Lululemon (LULU -0.9%) says it won&#39;t require customers to prove that yoga pants purchased from the retailer are too sheer before issuing a refund. Yesterday, a solitary report cropped up indicating a customer demonstration was required. Shares o... https://seekingalpha.com/news/913211?source=tweet\" data-url=\"https://seekingalpha.com/news/913211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913201\" data-ts=\"1364410422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRS\" target=\"_blank\">TRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TriMas (TRS +0.8%) acquires Wulfrun Specialised Fasteners for around $9.6M, subject to net...</a></h4><p>TriMas (<a href=\"https://seekingalpha.com/symbol/TRS\" title=\"TriMas Corporation\">TRS</a> <font color=\"green\">+0.8%</font>) acquires Wulfrun Specialised Fasteners for around $9.6M, subject to net working capital adjustments. Wulfrun is a manufacturer and distributer of specialty bolting and CNC machined components for use in oil and gas, pipeline and power generation applications. which generated approximately $10M in revenue in 2012.</p><div class=\"tiny-share-widget\" data-id=\"913201\" data-linked=\"TriMas (TRS +0.8%) acquires Wulfrun Specialised Fasteners for around $9.6M, subject to net...\" data-tweet=\"$TRS - TriMas (TRS +0.8%) acquires Wulfrun Specialised Fasteners for around $9.6M, subject to net working capital adjustments. Wulfrun is a manufacturer and distributer of specialty bolting and CNC machined components for use in oil and gas, pipeline an... https://seekingalpha.com/news/913201?source=tweet\" data-url=\"https://seekingalpha.com/news/913201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912601\" data-ts=\"1364408160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere Energy (LNG +2.4%) enjoys an afternoon pop after BTIG raises its price target on the...</a></h4><p>Cheniere Energy (<a href=\"https://seekingalpha.com/symbol/LNG\" title=\"Cheniere Energy, Inc\">LNG</a> <font color=\"green\">+2.4%</font>) enjoys an afternoon pop after BTIG <a href=\"http://www.streetinsider.com/Analyst+PT+Change/BTIG+Aggressively+Boosts+Price+Target+on+Cheniere+Energy+%28LNG%29+to+%2440/8214824.html\" target=\"_blank\">raises its price target</a> on the Buy-rated stock to $40 from $26. BTIG includes the contemplated fifth and sixth Sabine Pass liquefaction trains into its model assumptions for LNG after the company fulfilled most of the goals the firm had set for the company.</p><div class=\"tiny-share-widget\" data-id=\"912601\" data-linked=\"Cheniere Energy (LNG +2.4%) enjoys an afternoon pop after BTIG raises its price target on the...\" data-tweet=\"$LNG - Cheniere Energy (LNG +2.4%) enjoys an afternoon pop after BTIG raises its price target on the Buy-rated stock to $40 from $26. BTIG includes the contemplated fifth and sixth Sabine Pass liquefaction trains into its model assumptions for LNG after... https://seekingalpha.com/news/912601?source=tweet\" data-url=\"https://seekingalpha.com/news/912601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913101\" data-ts=\"1364408043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix (ZGNX -0.8%) and Battelle, the world&#39;s largest independent research and development...</a></h4><p>Zogenix (<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a> <font color=\"red\">-0.8%</font>) and Battelle, the world's largest independent research and development organization, say they've extended a co-marketing partnership for the DosePro needle-free drug delivery system through March, 2014. The partnership is focused on advancing the out-licensing opportunities for the system, with a focus on co-marketing the technology to potential biopharmaceutical and government clients.</p><div class=\"tiny-share-widget\" data-id=\"913101\" data-linked=\"Zogenix (ZGNX -0.8%) and Battelle, the world&#39;s largest independent research and development...\" data-tweet=\"$ZGNX - Zogenix (ZGNX -0.8%) and Battelle, the world&#39;s largest independent research and development organization, say they&#39;ve extended a co-marketing partnership for the DosePro needle-free drug delivery system through March, 2014. The partnership is fo... https://seekingalpha.com/news/913101?source=tweet\" data-url=\"https://seekingalpha.com/news/913101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913071\" data-ts=\"1364407477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NJDCY\" target=\"_blank\">NJDCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japanese manufacturer Nidec (NJ +2.3%) announces plans to establish Nidec Automotive Motor...</a></h4><p>Japanese manufacturer Nidec (NJ <font color=\"green\">+2.3%</font>) announces plans to establish Nidec Automotive Motor Americas Corporation as the strategic base for its automotive motor business in markets in the Americas. The company, which bought Illinois-based motor manufacturer Kinetek last year, has set a capital and capital reserve of $41.3M for the venture.</p><div class=\"tiny-share-widget\" data-id=\"913071\" data-linked=\"Japanese manufacturer Nidec (NJ +2.3%) announces plans to establish Nidec Automotive Motor...\" data-tweet=\"$NJDCY - Japanese manufacturer Nidec (NJ +2.3%) announces plans to establish Nidec Automotive Motor Americas Corporation as the strategic base for its automotive motor business in markets in the Americas. The company, which bought Illinois-based motor m... https://seekingalpha.com/news/913071?source=tweet\" data-url=\"https://seekingalpha.com/news/913071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913041\" data-ts=\"1364406436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine Biosciences (NBIX +22%) gains after announcing earlier that its initiated Phase IIb...</a></h4><p>Neurocrine Biosciences (<a href=\"https://seekingalpha.com/symbol/NBIX\" title=\"Neurocrine Biosciences, Inc.\">NBIX</a> <font color=\"green\">+22%</font>) gains after announcing earlier that its initiated Phase IIb clinical trials to evaluate Elagolix for the treatment of uterine fibroids. Elagolix is an oral gonadotropin-releasing hormone antagonist currently in collaborative development by its partner AbbVie (<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a> <font color=\"red\">-0.4%</font>).</p><div class=\"tiny-share-widget\" data-id=\"913041\" data-linked=\"Neurocrine Biosciences (NBIX +22%) gains after announcing earlier that its initiated Phase IIb...\" data-tweet=\"$NBIX $NBIX $ABBV - Neurocrine Biosciences (NBIX +22%) gains after announcing earlier that its initiated Phase IIb clinical trials to evaluate Elagolix for the treatment of uterine fibroids. Elagolix is an oral gonadotropin-releasing hormone antagonist ... https://seekingalpha.com/news/913041?source=tweet\" data-url=\"https://seekingalpha.com/news/913041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913031\" data-ts=\"1364405860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle (AXL +4.3%) rallies after dipping slightly in Tuesday&#39;s post-trading session, when...</a></h4><p>American Axle (<a href=\"https://seekingalpha.com/symbol/AXL\" title=\"American Axle &amp; Manufacturing Holdings, Inc.\">AXL</a> <font color=\"green\">+4.3%</font>) rallies after dipping slightly in Tuesday's post-trading session, when it disclosed its <a href=\"http://www.sec.gov/Archives/edgar/data/1062231/000106223113000016/axl_updated2013x3262013.htm\" target=\"_blank\">FY13 outlook</a>. The company anticipates FY13 sales to be $3.25B, slightly below the consensus estimate of $3.27B, adding that it expects the labor strike at <a href=\"https://seekingalpha.com/symbol/GM\" title=\"General Motors Company\">GM</a>'s Rayong factory in Thailand to have an estimated adverse impact on Q1 sales of approximately $15M. However, it also said its rate of sales has increased to about 15M vehicle units in FY13 from 14.4M vehicle units in FY12, which is fueling the upside move today.</p><div class=\"tiny-share-widget\" data-id=\"913031\" data-linked=\"American Axle (AXL +4.3%) rallies after dipping slightly in Tuesday&#39;s post-trading session, when...\" data-tweet=\"$AXL $AXL $GM - American Axle (AXL +4.3%) rallies after dipping slightly in Tuesday&#39;s post-trading session, when it disclosed its FY13 outlook. The company anticipates FY13 sales to be $3.25B, slightly below the consensus estimate of $3.27B, adding that... https://seekingalpha.com/news/913031?source=tweet\" data-url=\"https://seekingalpha.com/news/913031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"913011\" data-ts=\"1364405420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/913011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Next-gen firewalls (NGFWs) address a security hardware market Gartner thinks will be worth $9B...</a></h4>Next-gen firewalls (NGFWs) address a security hardware market Gartner thinks will be worth $9B in 2016, <a target=\"_blank\" href=\"http://www.streetinsider.com/New+Coverage/Needham+%26+Company+Starts+Palo+Alto+Networks+%28PANW%29+at+Buy%3B+Next+Generation+Firewall+to+Drive+Growth/8213791.html\">writes Needham</a>, which is starting NGFW leader Palo Alto Networks (<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color=\"green\">+3.7%</font>) with a Buy and $70 PT. Needham sees NGFWs, which support deeper content analysis than traditional firewalls, addressing several major security trends. Among them: the need to control \"risky\" Web services such as chat, the rise of <a target=\"_blank\" href=\"http://en.wikipedia.org/wiki/Advanced_persistent_threat\">APT attacks</a>, the mobile and <a target=\"_blank\" href=\"http://en.wikipedia.org/wiki/Bring_your_own_device\">BYOD</a> trends, and the network complexity and security risks spawned by virtualization and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=software-defined%20networking\">software-defined networking</a>.<div class=\"tiny-share-widget\" data-id=\"913011\" data-linked=\"Next-gen firewalls (NGFWs) address a security hardware market Gartner thinks will be worth $9B...\" data-tweet=\"$PANW - Next-gen firewalls (NGFWs) address a security hardware market Gartner thinks will be worth $9B in 2016, writes Needham, which is starting NGFW leader Palo Alto Networks (PANW +3.7%) with a Buy and $70 PT. Needham sees NGFWs, which support deeper... https://seekingalpha.com/news/913011?source=tweet\" data-url=\"https://seekingalpha.com/news/913011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912981\" data-ts=\"1364404552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viropharma (VPHM +4.3%) gets a lift today from a valuation upgrade to Overweight at JPMorgan...</a></h4><p>Viropharma (<a href=\"https://seekingalpha.com/symbol/VPHM\" title=\"\">VPHM</a> <font color=\"green\">+4.3%</font>) gets a lift today from a <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/ViroPharma+%28VPHM%29+Undervalued%2C+Competitive+Threats+Overstated+-+Analyst/8214766.html\">valuation upgrade</a> to Overweight at JPMorgan with a price target of $32 a share. Analyst Brian Abrahams thinks the competitive threats to <a href=\"https://seekingalpha.com/symbol/VPHM\" title=\"\">VPHM</a>'s Angioedema treatment Cinryze have been overstated relative to its peers, noting that although some early-stage treatments by its competitors are \"worth keeping an eye on,\" they have characteristics which make them a less-attractive alternative.</p><div class=\"tiny-share-widget\" data-id=\"912981\" data-linked=\"Viropharma (VPHM +4.3%) gets a lift today from a valuation upgrade to Overweight at JPMorgan...\" data-tweet=\"$SHPG - Viropharma (VPHM +4.3%) gets a lift today from a valuation upgrade to Overweight at JPMorgan with a price target of $32 a share. Analyst Brian Abrahams thinks the competitive threats to VPHM&#39;s Angioedema treatment Cinryze have been overstated re... https://seekingalpha.com/news/912981?source=tweet\" data-url=\"https://seekingalpha.com/news/912981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912971\" data-ts=\"1364403755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The insulin war heats up, as Sanofi (SNY -0.9%) loses a key pitchman to archrival Novo Nordisk...</a></h4><p>The insulin war heats up, as Sanofi (<a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> <font color=\"red\">-0.9%</font>) <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2013-03-26/novo-lures-sanofi-pitchman-as-diabetes-battle-heats-up.html\">loses a key pitchman</a> to archrival Novo Nordisk (NOVOB.PK). Former professional cyclist Phil Southerland, a diabetic whose team was funded by <a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> for the past six years, has jumped ship along with his crew, now calling themselves Team Novo Nordisk. The stakes in this battle are big, as the global diabetes drug market right now runs at around $35B and continues to climb. At present, <a href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\">SNY</a> dominates the market with Lantus, but its patent expires in 2015, and NOVOB - despite recent setbacks - continues to draft close behind.</p><div class=\"tiny-share-widget\" data-id=\"912971\" data-linked=\"The insulin war heats up, as Sanofi (SNY -0.9%) loses a key pitchman to archrival Novo Nordisk...\" data-tweet=\"$SNY - The insulin war heats up, as Sanofi (SNY -0.9%) loses a key pitchman to archrival Novo Nordisk (NOVOB.PK). Former professional cyclist Phil Southerland, a diabetic whose team was funded by SNY for the past six years, has jumped ship along with hi... https://seekingalpha.com/news/912971?source=tweet\" data-url=\"https://seekingalpha.com/news/912971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912931\" data-ts=\"1364403297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHCI\" target=\"_blank\">CHCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: CHCI +45%. RVLT +35%. UEPS +24%. LIVE +20%. UTSI +20%. ECYT +11%. MFRM...</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/CHCI' title='Comstock Homebuilding Companies, Inc.'>CHCI</a> <font color=\"green\">+45%</font>. <a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a> <font color=\"green\">+35%</font>. <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a> <font color=\"green\">+24%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/UTSI' title='UTStarcom, Inc.'>UTSI</a> <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/MFRM' title='Mattress Firm Holding Corp.'>MFRM</a> <font color=\"green\">+10%</font>. STSI <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/PGTI' title='PGT Innovations, Inc.'>PGTI</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/GSL' title='Global Ship Lease, Inc'>GSL</a> <font color=\"green\">+10%</font>.<br /> <b>Midday top 10 losers:</b> ASTM <font color=\"red\">-38%</font>. <a href='https://seekingalpha.com/symbol/EVBS' title='Eastern Virginia Bankshares, Inc.'>EVBS</a> <font color=\"red\">-23%</font>. <a href='https://seekingalpha.com/symbol/ISNS' title='Image Sensing Systems, Inc.'>ISNS</a> <font color=\"red\">-19%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color=\"red\">-15%</font>. <a href='https://seekingalpha.com/symbol/BAA' title='Banro Corporation'>BAA</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/GV' title='Goldfield Corp &#40;The&#41;'>GV</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a> <font color=\"red\">-11%</font>. MBLX <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color=\"red\">-10%</font>.<div class=\"tiny-share-widget\" data-id=\"912931\" data-linked=\"Midday top 10 gainers: CHCI +45%. RVLT +35%. UEPS +24%. LIVE +20%. UTSI +20%. ECYT +11%. MFRM...\" data-tweet=\"$CHCI $CHCI $RVLT - Midday top 10 gainers: CHCI +45%. RVLT +35%. UEPS +24%. LIVE +20%. UTSI +20%. ECYT +11%. MFRM +10%. STSI +10%. PGTI +10%. GSL +10%. Midday top 10 losers: ASTM -38%. EVBS -23%. ISNS -19%. ATOS -14%. CLF -15%. BAA -13%. GV -12%. LOGM -... https://seekingalpha.com/news/912931?source=tweet\" data-url=\"https://seekingalpha.com/news/912931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912891\" data-ts=\"1364402787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy (BBY -3.8%) slips lower after S&amp;amp;P Capital IQ cuts its rating on the retailer to...</a></h4>Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='red'>-3.8%</font>) slips lower after S&amp;P Capital IQ <a href=\"https://twitter.com/terranovajoe/status/316843712976125953\" target=\"_blank\">cuts</a> its rating on the retailer to Sell from Hold on a valuation call.<div class=\"tiny-share-widget\" data-id=\"912891\" data-linked=\"Best Buy (BBY -3.8%) slips lower after S&amp;amp;P Capital IQ cuts its rating on the retailer to...\" data-tweet=\"$BBY - Best Buy (BBY -3.8%) slips lower after S&amp;P Capital IQ cuts its rating on the retailer to Sell from Hold on a valuation call. https://seekingalpha.com/news/912891?source=tweet\" data-url=\"https://seekingalpha.com/news/912891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912871\" data-ts=\"1364402578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VASC\" target=\"_blank\">VASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC...</a></h4><p>Investors shrug off what appears to be old news about an <a href=\"http://www.benzinga.com/news/13/03/3451487/fda-announces-class-i-recall-of-some-vascular-solutions-guardian-ii-valve\" target=\"_blank\">FDA recall</a> of Vascular Solutions (<a href=\"https://seekingalpha.com/symbol/VASC\" title=\"Vascular Solutions, Inc.\">VASC</a> <font color=\"green\">+5.3%</font>) Guardian II valve, pushing the stock higher after Piper Jaffray <a href=\"http://www.streetinsider.com/New+Coverage/Piper+Jaffray+Starts+Vascular+Solutions+%28VASC%29+at+Overweight/8213782.html\" target=\"_blank\">initiated the shares</a> with an Overweight rating and an $18 price target. The company had issued its own recall of the valve earlier this month, citing a slightly increased risk of air leakage that may lead to an air embolism, which could result in serious injury or death.</p><div class=\"tiny-share-widget\" data-id=\"912871\" data-linked=\"Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC...\" data-tweet=\"$VASC - Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC +5.3%) Guardian II valve, pushing the stock higher after Piper Jaffray initiated the shares with an Overweight rating and an $18 price target. The co... https://seekingalpha.com/news/912871?source=tweet\" data-url=\"https://seekingalpha.com/news/912871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912841\" data-ts=\"1364401738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAA\" target=\"_blank\">BAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banro (BAA -12.1%) shares sink on earlier news the gold explorer plans an offering of common and...</a></h4><p>Banro (<a href=\"https://seekingalpha.com/symbol/BAA\" title=\"Banro Corporation\">BAA</a> <font color=\"red\">-12.1%</font>) shares sink on earlier news the gold explorer plans an <a target=\"_blank\" href=\"http://finance.yahoo.com/news/banro-announces-financing-plan-us-120000659.html\">offering</a> of common and preferred shares to raise up to $100M and posts a <a target=\"_blank\" href=\"http://finance.yahoo.com/news/banro-announces-end-2012-financial-114833700.html\">Q4 profit</a> of $0.03/share; 19,840 oz. of gold were sold at an average price of $1,711/oz.</p><div class=\"tiny-share-widget\" data-id=\"912841\" data-linked=\"Banro (BAA -12.1%) shares sink on earlier news the gold explorer plans an offering of common and...\" data-tweet=\"$BAA - Banro (BAA -12.1%) shares sink on earlier news the gold explorer plans an offering of common and preferred shares to raise up to $100M and posts a Q4 profit of $0.03/share; 19,840 oz. of gold were sold at an average price of $1,711/oz. https://seekingalpha.com/news/912841?source=tweet\" data-url=\"https://seekingalpha.com/news/912841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912801\" data-ts=\"1364401187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Estimate cuts from Pac Crest&#39;s Andy Hargreaves are helping Apple (AAPL -2%) underperform. Citing...</a></h4><a target=\"_blank\" href=\"http://blogs.barrons.com/techtraderdaily/2013/03/27/aapl-pac-crest-cuts-ipad-view-as-tablets-go-smaller-cheaper/\">Estimate cuts</a> from Pac Crest's Andy Hargreaves are helping Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color=\"red\">-2%</font>) underperform. Citing weak demand for the 9.7\" iPad - he thinks this is likely \"a sustained trend\" as <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/883291\">demand shifts</a> to smaller/cheaper tablets - and a demand pause ahead of a refresh, Hargreaves is cutting his FQ3 (June quarter) iPad forecast to 15M units from 18.5M. He also thinks \"the high end of the smartphone market is quickly becoming saturated,\" and has lowered FQ2 and FQ4 revenue/EPS estimates further below consensus. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/764401\">Hargreaves cut Apple</a> to Sector Perform on Jan. 16, when shares were at $503.<div class=\"tiny-share-widget\" data-id=\"912801\" data-linked=\"Estimate cuts from Pac Crest&#39;s Andy Hargreaves are helping Apple (AAPL -2%) underperform. Citing...\" data-tweet=\"$AAPL - Estimate cuts from Pac Crest&#39;s Andy Hargreaves are helping Apple (AAPL -2%) underperform. Citing weak demand for the 9.7&quot; iPad - he thinks this is likely &quot;a sustained trend&quot; as demand shifts to smaller/cheaper tablets - and a demand pause ahead ... https://seekingalpha.com/news/912801?source=tweet\" data-url=\"https://seekingalpha.com/news/912801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912771\" data-ts=\"1364400287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea Biopharmaceuticals (NAVB +0.8%) bucks a weak tape after saying it&#39;s commenced enrollment...</a></h4><p>Navidea Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+0.8%</font>) bucks a weak tape after saying it's commenced enrollment in Phase 2b positron emission tomography imaging studies of NAV4694, a scan for detecting cerebral-amyloid plaque in subjects diagnosed with Mild Cognitive Impairment. The study is designed to investigate whether scan findings have the ability to distinguish between subjects with MCI who progress to Alzheimer's disease from those who do not.</p><div class=\"tiny-share-widget\" data-id=\"912771\" data-linked=\"Navidea Biopharmaceuticals (NAVB +0.8%) bucks a weak tape after saying it&#39;s commenced enrollment...\" data-tweet=\"$NAVB - Navidea Biopharmaceuticals (NAVB +0.8%) bucks a weak tape after saying it&#39;s commenced enrollment in Phase 2b positron emission tomography imaging studies of NAV4694, a scan for detecting cerebral-amyloid plaque in subjects diagnosed with Mild Co... https://seekingalpha.com/news/912771?source=tweet\" data-url=\"https://seekingalpha.com/news/912771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912741\" data-ts=\"1364399777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back...</a></h4><p>Catalyst Pharmaceutical Partners (<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"red\">-1.9%</font>) slips into the red after opening <font color=\"green\">+8%</font> on the back of its earlier announcement that the independent Data Monitoring Committee overseeing <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a>'s Phase III clinical trials of Firdapse, a potential treatment for Lambert-Easton Myasthenic Syndrome, gave the go-ahead to continue the trial as planned based on a review of safety and clinical data.</p><div class=\"tiny-share-widget\" data-id=\"912741\" data-linked=\"Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back...\" data-tweet=\"$CPRX - Catalyst Pharmaceutical Partners (CPRX -1.9%) slips into the red after opening +8% on the back of its earlier announcement that the independent Data Monitoring Committee overseeing CPRX&#39;s Phase III clinical trials of Firdapse, a potential treatm... https://seekingalpha.com/news/912741?source=tweet\" data-url=\"https://seekingalpha.com/news/912741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912701\" data-ts=\"1364398542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GV\" target=\"_blank\">GV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldfield (GV -15%) takes a hit today despite reporting solid FY12 results late yesterday. Net...</a></h4><p>Goldfield (<a href=\"https://seekingalpha.com/symbol/GV\" title=\"Goldfield Corp (The)\">GV</a> <font color=\"red\">-15%</font>) takes a hit today despite reporting solid FY12 results late yesterday. Net income increased in 2012 to $0.47 per share from $0.03 per share in FY11, while revenue came in at $81.6M in FY12, up from $32.8M the prior year. On the surface, these numbers may be encouraging, but <a href=\"https://seekingalpha.com/article/1302171-goldfield-corp-unsustainable-margins-and-declining-backlog\" target=\"_blank\">Seeking Alpha contributor</a> Sarah Tyler thinks thinks the company's declining backlog and over-reaching margins point to more difficult times ahead for the utility transmission and distribution contractor.</p><div class=\"tiny-share-widget\" data-id=\"912701\" data-linked=\"Goldfield (GV -15%) takes a hit today despite reporting solid FY12 results late yesterday. Net...\" data-tweet=\"$GV - Goldfield (GV -15%) takes a hit today despite reporting solid FY12 results late yesterday. Net income increased in 2012 to $0.47 per share from $0.03 per share in FY11, while revenue came in at $81.6M in FY12, up from $32.8M the prior year. On the... https://seekingalpha.com/news/912701?source=tweet\" data-url=\"https://seekingalpha.com/news/912701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912641\" data-ts=\"1364397630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMTOY\" target=\"_blank\">MMTOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Just when you think the smoke has cleared: Mitsubishi Motors (OTC:MMTOY) reports two recent...</a></h4>Just when you think the smoke has cleared: Mitsubishi Motors (<a href='https://seekingalpha.com/symbol/MMTOY' title='Mitsubishi Motors ADR'>OTC:MMTOY</a>) reports <a href=\"http://online.wsj.com/article/SB10001424127887324000704578386232692283670.html\" target=\"_blank\">two recent accidents</a> involving lithium-ion batteries manufactured by its joint venture with GS Yuasa (<a href='https://seekingalpha.com/symbol/GYUAF' title='Gs Yuasa Corp.'>OTCPK:GYUAF</a>), the maker of batteries used in Boeing's (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"red\">-1.1%</font>) grounded 787 Dreamliner. The Japanese auto maker said a lithium-ion battery pack used in its i-MiEV model electric car caught fire while charging during a test inspection at a company plant in Okayama last week, while in another incident, a battery installed in one of its Outlander PHEV hybrids overheated, melting the cell and part of the battery pack.<div class=\"tiny-share-widget\" data-id=\"912641\" data-linked=\"Just when you think the smoke has cleared: Mitsubishi Motors (OTC:MMTOY) reports two recent...\" data-tweet=\"$MMTOY $MMTOY $GYUAF - Just when you think the smoke has cleared: Mitsubishi Motors (OTC:MMTOY) reports two recent accidents involving lithium-ion batteries manufactured by its joint venture with GS Yuasa (OTCPK:GYUAF), the maker of batteries used in Bo... https://seekingalpha.com/news/912641?source=tweet\" data-url=\"https://seekingalpha.com/news/912641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912611\" data-ts=\"1364396782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More commentary on Cliffs Natural Resources (CLF -13.3%) comes from Cowen&#39;s Anthony Rizzuto...</a></h4><a target=\"_blank\" href=\"http://blogs.barrons.com/stockstowatchtoday/2013/03/27/cliffs-down-12-today-51-in-2013\">More commentary</a> on Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-13.3%</font>) comes from Cowen's Anthony Rizzuto after meeting with CEO Joe Carrabba yesterday. Cowen thinks CLF is taking a \"somewhat aggressive stance\" on supply in the  industry; CLF says moves by global iron ore producers away from  greenfield investment could lead to a supply crunch over the medium term. (earlier:<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/911711\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/912511\">II</a>)<div class=\"tiny-share-widget\" data-id=\"912611\" data-linked=\"More commentary on Cliffs Natural Resources (CLF -13.3%) comes from Cowen&#39;s Anthony Rizzuto...\" data-tweet=\"$CLF - More commentary on Cliffs Natural Resources (CLF -13.3%) comes from Cowen&#39;s Anthony Rizzuto after meeting with CEO Joe Carrabba yesterday. Cowen thinks CLF is taking a &quot;somewhat aggressive stance&quot; on supply in the industry; CLF says moves by glob... https://seekingalpha.com/news/912611?source=tweet\" data-url=\"https://seekingalpha.com/news/912611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912571\" data-ts=\"1364396327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DS\" target=\"_blank\">DS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buy the (rapidly disappearing) dip in Newcastle Investment (NCT +3.2%) says UBS, waving off last...</a></h4><p>Buy the (rapidly disappearing) dip in Newcastle Investment (NCT <font color=\"green\">+3.2%</font>) says UBS, <a href=\"http://wallstcheatsheet.com/stocks/analysts-micron-technology-has-a-material-advantage-and-4-new-opinions-investors-must-read.html/2/\" target=\"_blank\">waving off last week's weakness</a> as needless concern about higher prepayments and the impact on the MSR portfolio from the imminent spinoff of New Residential. UBS gives the still-combined operation a price target of $14.</p><div class=\"tiny-share-widget\" data-id=\"912571\" data-linked=\"Buy the (rapidly disappearing) dip in Newcastle Investment (NCT +3.2%) says UBS, waving off last...\" data-tweet=\"$DS - Buy the (rapidly disappearing) dip in Newcastle Investment (NCT +3.2%) says UBS, waving off last week&#39;s weakness as needless concern about higher prepayments and the impact on the MSR portfolio from the imminent spinoff of New Residential. UBS giv... https://seekingalpha.com/news/912571?source=tweet\" data-url=\"https://seekingalpha.com/news/912571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912551\" data-ts=\"1364395896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Look for Trulia (TRLA +1.8%) to close its valuation gap with Zillow (Z -0.3%), writes Deutsche&#39;s...</a></h4>Look for Trulia (TRLA <font color='green'>+1.8%</font>) to close its valuation gap with Zillow (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color='red'>-0.3%</font>), writes Deutsche's <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/03/3450380/update-deutsche-bank-upgrades-trulia-to-buy-on-closing-v\" target=\"_blank\">Lloyd Walmsley</a>, who's upgrading the former to Buy. Whereas Zillow has risen 23% since Feb. 15 (going into today), Trulia has fallen 14%, and its 2014E <a href=\"http://en.wikipedia.org/wiki/EV/EBITDA\" target=\"_blank\">EV/EBITDA</a> multiple is now 21% lower. Walmsley argues Trulia's <a href=\"https://seekingalpha.com/currents/post/865881\" target=\"_blank\">follow-on offering</a> strengthens its M&amp;A flexibility, and sees the company delivering \"a more articulated strategy to deepen agent relationships over time.\"<div class=\"tiny-share-widget\" data-id=\"912551\" data-linked=\"Look for Trulia (TRLA +1.8%) to close its valuation gap with Zillow (Z -0.3%), writes Deutsche&#39;s...\" data-tweet=\"$Z - Look for Trulia (TRLA +1.8%) to close its valuation gap with Zillow (Z -0.3%), writes Deutsche&#39;s Lloyd Walmsley, who&#39;s upgrading the former to Buy. Whereas Zillow has risen 23% since Feb. 15 (going into today), Trulia has fallen 14%, and its 2014E ... https://seekingalpha.com/news/912551?source=tweet\" data-url=\"https://seekingalpha.com/news/912551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912531\" data-ts=\"1364395347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENZN\" target=\"_blank\">ENZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enzon Pharmaceuticals (OTC:ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory...</a></h4>Enzon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ENZN' title='Enzon Pharmaceuticals, Inc.'>OTC:ENZN</a> <font color=\"red\">-2.8%</font>) hits a new 52-week low after disclosing in a <a href=\"http://www.sec.gov/Archives/edgar/data/727510/000114420413017546/v339391_8k.htm\" target=\"_blank\">regulatory filing</a> late yesterday that it's reducing its workforce from 19 employees to 12. It expects to incur about $1.3M in charges related to the reduction in force, due to cash expenditures for one-time employee termination benefits and associated costs. The company expects to record the charges and complete the reduction by the end of Q1.<div class=\"tiny-share-widget\" data-id=\"912531\" data-linked=\"Enzon Pharmaceuticals (OTC:ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory...\" data-tweet=\"$ENZN - Enzon Pharmaceuticals (OTC:ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory filing late yesterday that it&#39;s reducing its workforce from 19 employees to 12. It expects to incur about $1.3M in charges related to the reduction in... https://seekingalpha.com/news/912531?source=tweet\" data-url=\"https://seekingalpha.com/news/912531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912521\" data-ts=\"1364395154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney&#39;s (JCP -1.1%) new &quot;mark-up to mark-down&quot; tactic may be straight from Retail 101 but...</a></h4><p>J.C. Penney's (<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a> <font color=\"red\">-1.1%</font>) new \"mark-up to mark-down\" <a href=\"https://seekingalpha.com/currents/post/911341\" target=\"_blank\">tactic</a> may be straight from Retail 101 but it's a <a href=\"http://www.nypost.com/p/news/business/as_the_ron_turns_Z4Na2xr60LPwePCXCLzagO\" target=\"_blank\">tough row</a> to hoe for a company suffering +20% drops in sales, according to analysts. Is JCP making the transition smoothly?  Eyes in the street note that items in stores are \"awkwardly\" displaying stickers over the older prices in an effort to cover them up.</p><div class=\"tiny-share-widget\" data-id=\"912521\" data-linked=\"J.C. Penney&#39;s (JCP -1.1%) new &quot;mark-up to mark-down&quot; tactic may be straight from Retail 101 but...\" data-tweet=\"$JCP - J.C. Penney&#39;s (JCP -1.1%) new &quot;mark-up to mark-down&quot; tactic may be straight from Retail 101 but it&#39;s a tough row to hoe for a company suffering +20% drops in sales, according to analysts. Is JCP making the transition smoothly? Eyes in the street ... https://seekingalpha.com/news/912521?source=tweet\" data-url=\"https://seekingalpha.com/news/912521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912511\" data-ts=\"1364395143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">This morning&#39;s crippling downgrades of Cliffs Natural Resources (CLF -12.9%) send shares,...</a></h4><p>This morning's <a href=\"https://seekingalpha.com/currents/post/911711\" target=\"_blank\">crippling downgrades</a> of Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-12.9%</font>) send shares, already -51% YTD, plunging to four-year lows. Morgan Stanley believes CLF's U.S. iron ore business, ~60% of 2012 EBITDA, will be <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/03/27/futures-falling-cliffs-plunges-13/\" target=\"_blank\">cut in half</a> in coming years as new Great Lakes supply cuts into volumes and pricing. Credit Suisse offers similar concerns. Morgan's bear case for CLF shares: <a target=\"_blank\" href=\"https://twitter.com/thenotablecalls/status/316864048849371136\">$1</a>. CS bear case: <a target=\"_blank\" href=\"https://twitter.com/thenotablecalls/status/316864153916669952\">zero</a>.</p><div class=\"tiny-share-widget\" data-id=\"912511\" data-linked=\"This morning&#39;s crippling downgrades of Cliffs Natural Resources (CLF -12.9%) send shares,...\" data-tweet=\"$CLF - This morning&#39;s crippling downgrades of Cliffs Natural Resources (CLF -12.9%) send shares, already -51% YTD, plunging to four-year lows. Morgan Stanley believes CLF&#39;s U.S. iron ore business, ~60% of 2012 EBITDA, will be cut in half in coming years... https://seekingalpha.com/news/912511?source=tweet\" data-url=\"https://seekingalpha.com/news/912511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912471\" data-ts=\"1364394570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European tech and telecom stocks are underperforming as continental equities sell off on Italian...</a></h4>European tech and telecom stocks are underperforming as <a href=\"https://seekingalpha.com/currents/post/911601\" target=\"_blank\">continental equities sell off</a> on Italian concerns. <a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color=\"red\">-3.9%</font>. ALU <font color=\"red\">-2.3%</font>. <a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color=\"red\">-1.4%</font>. FTE <font color=\"red\">-4.3%</font>. <a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a> <font color=\"red\">-2.1%</font>. <a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a> <font color=\"red\">-4.3%</font>. <a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a> <font color=\"red\">-1.7%</font>. One exception is Nokia (<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color='green'>+0.3%</font>), which is benefiting from an upgrade to Buy from Swedbank.<div class=\"tiny-share-widget\" data-id=\"912471\" data-linked=\"European tech and telecom stocks are underperforming as continental equities sell off on Italian...\" data-tweet=\"$STM $STM $NOK - European tech and telecom stocks are underperforming as continental equities sell off on Italian concerns. STM -3.9%. ALU -2.3%. NXPI -1.4%. FTE -4.3%. TEF -2.1%. TI -4.3%. VOD -1.7%. One exception is Nokia (NOK +0.3%), which is benefit... https://seekingalpha.com/news/912471?source=tweet\" data-url=\"https://seekingalpha.com/news/912471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912441\" data-ts=\"1364394357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912441\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The battle for board seats at Agrium (AGU -3.2%) grew more complex overnight, as proxy advisory...</a></h4><p>The battle for board seats at Agrium (AGU <font color=\"red\">-3.2%</font>) grew more complex overnight, as proxy advisory firm ISS <a href=\"http://finance.yahoo.com/news/iss-recommends-two-jana-nominees-102200806.html\" target=\"_blank\">endorsed two dissident nominees</a> while Glass Lewis <a href=\"https://seekingalpha.com/currents/post/911801\" target=\"_blank\">backed AGU\u2019s entire slate</a>. \"A board still loudly repudiating the very changes it has begun to  implement... is a board with a burgeoning credibility problem,\" ISS writes; \"ISS simply got this one wrong,\"AGU <a href=\"http://finance.yahoo.com/news/agrium-comments-iss-report-124312046.html\" target=\"_blank\">responds</a>.</p><div class=\"tiny-share-widget\" data-id=\"912441\" data-linked=\"The battle for board seats at Agrium (AGU -3.2%) grew more complex overnight, as proxy advisory...\" data-tweet=\"$NTR - The battle for board seats at Agrium (AGU -3.2%) grew more complex overnight, as proxy advisory firm ISS endorsed two dissident nominees while Glass Lewis backed AGU\u2019s entire slate. &quot;A board still loudly repudiating the very changes it has begun ... https://seekingalpha.com/news/912441?source=tweet\" data-url=\"https://seekingalpha.com/news/912441\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912421\" data-ts=\"1364394037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VMware (VMW +1.2%) rises on a down day after ISI upgrades shares to Strong Buy from Buy. Shares...</a></h4><p>VMware (<a href=\"https://seekingalpha.com/symbol/VMW\" title=\"VMware, Inc.\">VMW</a> <font color=\"green\">+1.2%</font>) rises on a down day after ISI upgrades shares to Strong Buy from Buy. Shares have <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1364414400000&amp;chddm=5390&amp;chls=IntervalBasedLine&amp;q=NYSE:VMW&amp;ntsp=0&amp;ei=uf9SUaC_H7K1iALZWA\" target=\"_blank\">gradually given back</a> most of the big gains they saw earlier this month due to the <a href=\"https://seekingalpha.com/currents/post/886001\" target=\"_blank\">strong growth outlook</a> provided on the company's investor day.</p><div class=\"tiny-share-widget\" data-id=\"912421\" data-linked=\"VMware (VMW +1.2%) rises on a down day after ISI upgrades shares to Strong Buy from Buy. Shares...\" data-tweet=\"$VMW $DELL - VMware (VMW +1.2%) rises on a down day after ISI upgrades shares to Strong Buy from Buy. Shares have gradually given back most of the big gains they saw earlier this month due to the strong growth outlook provided on the company&#39;s investor ... https://seekingalpha.com/news/912421?source=tweet\" data-url=\"https://seekingalpha.com/news/912421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912361\" data-ts=\"1364393203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOL\" target=\"_blank\">AOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays upgrades AOL (AOL +8.4%) to Overweight, and sends shares to $39 in the process. After...</a></h4><p>Barclays upgrades AOL (<a href=\"https://seekingalpha.com/symbol/AOL\" title=\"AOL Inc.\">AOL</a> <font color=\"green\">+8.4%</font>) to Overweight, and sends shares to $39 in the process. After hitting a high of $43.93 in mid-February in the wake of <a href=\"https://seekingalpha.com/currents/post/815561\" target=\"_blank\">strong Q4 numbers</a>, AOL had gradually sold off, reaching a low of $33.58 on March 18.</p><div class=\"tiny-share-widget\" data-id=\"912361\" data-linked=\"Barclays upgrades AOL (AOL +8.4%) to Overweight, and sends shares to $39 in the process. After...\" data-tweet=\"$AOL - Barclays upgrades AOL (AOL +8.4%) to Overweight, and sends shares to $39 in the process. After hitting a high of $43.93 in mid-February in the wake of strong Q4 numbers, AOL had gradually sold off, reaching a low of $33.58 on March 18. https://seekingalpha.com/news/912361?source=tweet\" data-url=\"https://seekingalpha.com/news/912361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912351\" data-ts=\"1364393010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912351\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattress stocks in focus: Tempur Pedic (TPX +3.6%) trades higher after Mattress Firm (MFRM...</a></h4><p>Mattress stocks in focus: Tempur Pedic (<a href=\"https://seekingalpha.com/symbol/TPX\" title=\"Tempur Sealy International Inc.\">TPX</a> <font color=\"green\">+3.6%</font>) trades higher after Mattress Firm (<a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a> <font color=\"green\">+6.7%</font>) misses estimates with its Q4 earnings report and issues relatively in-line guidance. Though Raymond James is out with a <a href=\"https://seekingalpha.com/currents/post/911771\" target=\"_blank\">defense</a> on Mattress Firm, the momentum rally in the sector looks a bit overdone to some traders.</p><div class=\"tiny-share-widget\" data-id=\"912351\" data-linked=\"Mattress stocks in focus: Tempur Pedic (TPX +3.6%) trades higher after Mattress Firm (MFRM...\" data-tweet=\"$TPX $TPX $MFRM - Mattress stocks in focus: Tempur Pedic (TPX +3.6%) trades higher after Mattress Firm (MFRM +6.7%) misses estimates with its Q4 earnings report and issues relatively in-line guidance. Though Raymond James is out with a defense on Mattre... https://seekingalpha.com/news/912351?source=tweet\" data-url=\"https://seekingalpha.com/news/912351\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912301\" data-ts=\"1364392607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rackspace (RAX -3.4%) falls towards $50 after CLSA starts coverage with an Underperform and $52...</a></h4>Rackspace (<a href='https://seekingalpha.com/symbol/RAX' title='Rackspace Hosting, Inc.'>RAX</a> <font color='red'>-3.4%</font>) falls towards $50 after CLSA starts coverage with an Underperform and $52 PT. <a href=\"https://seekingalpha.com/currents/post/905421\" target=\"_blank\">Pac Crest downgraded</a> Rackspace to Sector Perform last week. Shares <font color=\"red\">-32%</font> YTD.<div class=\"tiny-share-widget\" data-id=\"912301\" data-linked=\"Rackspace (RAX -3.4%) falls towards $50 after CLSA starts coverage with an Underperform and $52...\" data-tweet=\"$RAX - Rackspace (RAX -3.4%) falls towards $50 after CLSA starts coverage with an Underperform and $52 PT. Pac Crest downgraded Rackspace to Sector Perform last week. Shares -32% YTD. https://seekingalpha.com/news/912301?source=tweet\" data-url=\"https://seekingalpha.com/news/912301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912251\" data-ts=\"1364392334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPT\" target=\"_blank\">GPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gramercy Capital (GKK) CEO Gordon Dugan added 2.5% to his stake in the company, purchasing 50K...</a></h4>Gramercy Capital (GKK) CEO Gordon Dugan added 2.5% to his stake in the company, <a href=\"http://www.sec.gov/Archives/edgar/data/1054811/000117911013005853/xslF345X03/edgar.xml\" target=\"_blank\">purchasing 50K shares</a> at $4.33 each last week following earnings and<a href=\"https://seekingalpha.com/currents/post/899671\" target=\"_blank\"> the update</a> on the company's business plan. The stock takes out another 52-week high today, <font color=\"green\">+4.6%</font> to $4.75.<div class=\"tiny-share-widget\" data-id=\"912251\" data-linked=\"Gramercy Capital (GKK) CEO Gordon Dugan added 2.5% to his stake in the company, purchasing 50K...\" data-tweet=\"$GPT - Gramercy Capital (GKK) CEO Gordon Dugan added 2.5% to his stake in the company, purchasing 50K shares at $4.33 each last week following earnings and the update on the company&#39;s business plan. The stock takes out another 52-week high today, +4.6% ... https://seekingalpha.com/news/912251?source=tweet\" data-url=\"https://seekingalpha.com/news/912251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912221\" data-ts=\"1364392043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCPI\" target=\"_blank\">RCPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Star Scientific (STSI) jumps 10.1% after apparently convincing investors with its response...</a></h4><p>Star Scientific (STSI) <font color=\"green\">jumps 10.1%</font> after apparently convincing investors with its <a href=\"https://seekingalpha.com/currents/post/911051\" target=\"_blank\">response</a> yesterday to a class action lawsuit that questions the validity of the company's research into its dietary supplements and cosmetic products. \"It is difficult to conceive of a more inappropriate class action plaintiff representative,\" Star said. (PR)</p><div class=\"tiny-share-widget\" data-id=\"912221\" data-linked=\"Star Scientific (STSI) jumps 10.1% after apparently convincing investors with its response...\" data-tweet=\"$RCPI - Star Scientific (STSI) jumps 10.1% after apparently convincing investors with its response yesterday to a class action lawsuit that questions the validity of the company&#39;s research into its dietary supplements and cosmetic products. &quot;It is diffi... https://seekingalpha.com/news/912221?source=tweet\" data-url=\"https://seekingalpha.com/news/912221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912211\" data-ts=\"1364392022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOF\" target=\"_blank\">BIOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioFuel Energy (BIOF -11.2%) slides after saying Tuesday night it has engaged Piper Jaffray to...</a></h4><p>BioFuel Energy (<a href=\"https://seekingalpha.com/symbol/BIOF\" title=\"BioFuel Energy Corp.\">BIOF</a> <font color=\"red\">-11.2%</font>) slides after saying Tuesday night it has engaged Piper Jaffray to help it pursue strategic alternatives for asset sales in connection with a default by the company's operating subsidiaries. Through December, unpaid principal and interest totaled $8.2M.<span class=\"Apple-converted-space\"></span></p><div class=\"tiny-share-widget\" data-id=\"912211\" data-linked=\"BioFuel Energy (BIOF -11.2%) slides after saying Tuesday night it has engaged Piper Jaffray to...\" data-tweet=\"$BIOF - BioFuel Energy (BIOF -11.2%) slides after saying Tuesday night it has engaged Piper Jaffray to help it pursue strategic alternatives for asset sales in connection with a default by the company&#39;s operating subsidiaries. Through December, unpaid p... https://seekingalpha.com/news/912211?source=tweet\" data-url=\"https://seekingalpha.com/news/912211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912191\" data-ts=\"1364391587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGP\" target=\"_blank\">FGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrellgas Partners (FGP -3.3%) sinks at the open, apparently the result of a Seeking Alpha blog...</a></h4><p>Ferrellgas Partners (<a href=\"https://seekingalpha.com/symbol/FGP\" title=\"Ferrellgas Partners L.P\">FGP</a> <font color=\"red\">-3.3%</font>) sinks at the open, apparently the result of a Seeking Alpha blog post that calls the stock \"<a href=\"https://seekingalpha.com/article/1302321-ferrellgas-a-balloon-ready-to-pop\" target=\"_blank\">a balloon ready to pop</a>... not only are the shares extremely overpriced, but that the 'income' investors are receiving is sustained only by an ever increasing  mountain of debt and perpetual issuance of new shares.\"</p><div class=\"tiny-share-widget\" data-id=\"912191\" data-linked=\"Ferrellgas Partners (FGP -3.3%) sinks at the open, apparently the result of a Seeking Alpha blog...\" data-tweet=\"$FGP - Ferrellgas Partners (FGP -3.3%) sinks at the open, apparently the result of a Seeking Alpha blog post that calls the stock &quot;a balloon ready to pop. not only are the shares extremely overpriced, but that the &#39;income&#39; investors are receiving is sus... https://seekingalpha.com/news/912191?source=tweet\" data-url=\"https://seekingalpha.com/news/912191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912181\" data-ts=\"1364391423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIG\" target=\"_blank\">HIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hartford Financial (HIG -1.6%) will record a charge of $200M in Q1 for its just-completed tender...</a></h4><p>Hartford Financial (<a href=\"https://seekingalpha.com/symbol/HIG\" title=\"Hartford Financial Services Group Inc.\">HIG</a> <font color=\"red\">-1.6%</font>) will record a charge of $200M in Q1 for its just-completed tender for $800M in senior notes. (PR)</p><div class=\"tiny-share-widget\" data-id=\"912181\" data-linked=\"Hartford Financial (HIG -1.6%) will record a charge of $200M in Q1 for its just-completed tender...\" data-tweet=\"$HIG - Hartford Financial (HIG -1.6%) will record a charge of $200M in Q1 for its just-completed tender for $800M in senior notes. (PR) https://seekingalpha.com/news/912181?source=tweet\" data-url=\"https://seekingalpha.com/news/912181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912161\" data-ts=\"1364391176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCEL\" target=\"_blank\">VCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aastrom Biosciences (ASTM) craters 32% out the gate after saying it plans to cut its staff and...</a></h4><p>Aastrom Biosciences (ASTM) <font color=\"red\">craters 32%</font> out the gate after saying it plans to cut its staff and operating costs by 50%, and end Phase III trials of its ixmyelocel-T drug for patients with  critical limb ischemia - when there is an sudden lack of blood flow to a limb - as it was unable to bring in a partner. Instead, Aastrom will focus on Phase 2b trials of ixCELL for treating dilated cardiomyopathy (heart muscle disease). (PR)</p><div class=\"tiny-share-widget\" data-id=\"912161\" data-linked=\"Aastrom Biosciences (ASTM) craters 32% out the gate after saying it plans to cut its staff and...\" data-tweet=\"$VCEL - Aastrom Biosciences (ASTM) craters 32% out the gate after saying it plans to cut its staff and operating costs by 50%, and end Phase III trials of its ixmyelocel-T drug for patients with critical limb ischemia - when there is an sudden lack of b... https://seekingalpha.com/news/912161?source=tweet\" data-url=\"https://seekingalpha.com/news/912161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912111\" data-ts=\"1364390711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHCI\" target=\"_blank\">CHCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: CHCI +51%. UTSI +23%. STSI +14%. VELT +12%. CHTP +11%. &amp;nbsp; Losers: ASTM...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/CHCI\" title=\"Comstock Homebuilding Companies, Inc.\">CHCI</a> <font color=\"green\">+51%</font>. <a href=\"https://seekingalpha.com/symbol/UTSI\" title=\"UTStarcom, Inc.\">UTSI</a> <font color=\"green\">+23%</font>. STSI <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/VELT\" title=\"\">VELT</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/CHTP\" title=\"Chelsea Therapeutics International, Ltd.\">CHTP</a> <font color=\"green\">+11%</font>.  <br><b>Losers:</b> ASTM <font color=\"red\">-37%</font>. <a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/GV\" title=\"Goldfield Corp (The)\">GV</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/LNDC\" title=\"Landec Corporation\">LNDC</a> <font color=\"red\">-6%</font>.<div class=\"tiny-share-widget\" data-id=\"912111\" data-linked=\"Premarket gainers: CHCI +51%. UTSI +23%. STSI +14%. VELT +12%. CHTP +11%.  Losers: ASTM -37%....\" data-tweet=\"$CHCI $CHCI $UTSI - Premarket gainers: CHCI +51%. UTSI +23%. STSI +14%. VELT +12%. CHTP +11%.  Losers: ASTM -37%. CLF -14%. GV -7%. LNDC -6%. https://seekingalpha.com/news/912111?source=tweet\" data-url=\"https://seekingalpha.com/news/912111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912071\" data-ts=\"1364390348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wal-Mart (NYSE:WMT) slips lower in premarket trading, down 0.8%, after the company says it...</a></h4><p>Wal-Mart (NYSE:<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a>) slips lower in premarket trading, <font color=\"red\">down 0.8%</font>, after the company says it <a href=\"http://cms.seekingalpha.com/currents/post/911351\" target=\"_blank\">expects losses</a> of around $157M (and counting) related to the Mexico bribery scandal. Though it's a big jump from the $99M in costs from just three months ago, analysts note the amount is about where they expected it to be.</p><div class=\"tiny-share-widget\" data-id=\"912071\" data-linked=\"Wal-Mart (NYSE:WMT) slips lower in premarket trading, down 0.8%, after the company says it...\" data-tweet=\"$WMT - Wal-Mart (NYSE:WMT) slips lower in premarket trading, down 0.8%, after the company says it expects losses of around $157M (and counting) related to the Mexico bribery scandal. Though it&#39;s a big jump from the $99M in costs from just three months a... https://seekingalpha.com/news/912071?source=tweet\" data-url=\"https://seekingalpha.com/news/912071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912051\" data-ts=\"1364390266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVR\" target=\"_blank\">DVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cal Dive (NYSE:DVR) -1.7% premarket after warning of lower than expected Q1 results due to the...</a></h4><p>Cal Dive (NYSE:<a href=\"https://seekingalpha.com/symbol/DVR\" title=\"Cal Dive International, Inc.\">DVR</a>) <font color=\"red\">-1.7%</font> premarket after warning of lower than expected Q1 results due to the cancellation of a vessel contract in Africa, lower than expected pricing for surface diving services in the Gulf of Mexico, and rising employee medical costs. DVR softened the blow with news of a lucrative subsea contract from Mexican state oil giant Pemex.</p><div class=\"tiny-share-widget\" data-id=\"912051\" data-linked=\"Cal Dive (NYSE:DVR) -1.7% premarket after warning of lower than expected Q1 results due to the...\" data-tweet=\"$DVR - Cal Dive (NYSE:DVR) -1.7% premarket after warning of lower than expected Q1 results due to the cancellation of a vessel contract in Africa, lower than expected pricing for surface diving services in the Gulf of Mexico, and rising employee medical... https://seekingalpha.com/news/912051?source=tweet\" data-url=\"https://seekingalpha.com/news/912051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912061\" data-ts=\"1364390118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: The S&amp;amp;P may again miss out on setting a new record after finishing yesterday...</a></h4><b>Market preview:</b> The S&amp;P may again miss out on setting a new record after finishing yesterday just two points short of its highest close, with U.S. futures <a href=\"http://www.marketwatch.com/story/stock-index-futures-edge-lower-on-italy-concerns-2013-03-27\" target=\"_blank\">dragged down</a> by the eurozone. The S&amp;P Mini is <font color=\"red\">-0.45%</font>. Adding to <a href=\"https://seekingalpha.com/currents/search?query=cyprus\" target=\"_blank\">fears about Cyprus</a>, Italy is <a href=\"https://seekingalpha.com/currents/post/911601\" target=\"_blank\">as far away as ever</a> from a new government. Cliffs Natural Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a>) <font color=\"red\">collapses 12.9%</font> <a href=\"https://seekingalpha.com/currents/post/911711\" target=\"_blank\">following</a> downgrades. <a href=\"https://seekingalpha.com/currents/post/911081\" target=\"_blank\">Later</a>: Pending Home Sales, Fed speak<div class=\"tiny-share-widget\" data-id=\"912061\" data-linked=\"Market preview: The S&amp;amp;P may again miss out on setting a new record after finishing yesterday...\" data-tweet=\"$CLF - Market preview: The S&amp;P may again miss out on setting a new record after finishing yesterday just two points short of its highest close, with U.S. futures dragged down by the eurozone. The S&amp;P Mini is -0.45%. Adding to fears about Cyprus, Italy i... https://seekingalpha.com/news/912061?source=tweet\" data-url=\"https://seekingalpha.com/news/912061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912041\" data-ts=\"1364390043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VELTF\" target=\"_blank\">VELTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Velti (VELT) +12.9% after launching a mobile ad network that will compete with Millennial Media...</a></h4><p>Velti (<a href=\"https://seekingalpha.com/symbol/VELT\" title=\"\">VELT</a>) <font color=\"green\">+12.9%</font> after launching a mobile ad network that will compete with Millennial Media (NYSE:<a href=\"https://seekingalpha.com/symbol/MM\" title=\"Millennial Media, Inc.\">MM</a>), Google's AdMob, and Apple's iAd. Velti boasts it's the only firm to offer both a mobile ad network and marketing/ad agency solutions, and (through a new analytics platform) to enable targeted ad campaigns that span mobile devices and PCs (<a href=\"https://seekingalpha.com/currents/post/728861\" target=\"_blank\">Facebook </a>has been toying with doing something similar). \"We can bring a lot of marketing data [that other networks do not have], which is very valuable,\" <a href=\"http://www.businessinsider.com/velti-launches-an-ad-network-to-compete-against-googles-admob-and-millennial-media-2013-3\" target=\"_blank\">Velti's CMO tells BI</a>. 37.9% of the float was shorted as of Feb. 28. (<a href=\"https://seekingalpha.com/currents/post/884091\" target=\"_blank\">Q1/2013 guidance</a>)</p><div class=\"tiny-share-widget\" data-id=\"912041\" data-linked=\"Velti (VELT) +12.9% after launching a mobile ad network that will compete with Millennial Media...\" data-tweet=\"$VELTF $VELTF $MM - Velti (VELT) +12.9% after launching a mobile ad network that will compete with Millennial Media (NYSE:MM), Google&#39;s AdMob, and Apple&#39;s iAd. Velti boasts it&#39;s the only firm to offer both a mobile ad network and marketing/ad agency sol... https://seekingalpha.com/news/912041?source=tweet\" data-url=\"https://seekingalpha.com/news/912041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"912031\" data-ts=\"1364390009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTSI\" target=\"_blank\">UTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/912031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of UTStarcom (NASDAQ:UTSI) soar 26.4% premarket to $2.98 after the company receives a...</a></h4><p>Shares of UTStarcom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/UTSI\" title=\"UTStarcom, Inc.\">UTSI</a>) <font color=\"green\">soar 26.4%</font> premarket to $2.98 after the company receives a <a href=\"http://cms.seekingalpha.com/currents/post/911481\" target=\"_blank\">buyout offer</a> at $3.20 a share.</p><div class=\"tiny-share-widget\" data-id=\"912031\" data-linked=\"Shares of UTStarcom (NASDAQ:UTSI) soar 26.4% premarket to $2.98 after the company receives a...\" data-tweet=\"$UTSI - Shares of UTStarcom (NASDAQ:UTSI) soar 26.4% premarket to $2.98 after the company receives a buyout offer at $3.20 a share. https://seekingalpha.com/news/912031?source=tweet\" data-url=\"https://seekingalpha.com/news/912031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911991\" data-ts=\"1364389482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy (NASDAQ:ENPH) -4.9% premarket after Raymond James downgrades shares to...</a></h4><p>Enphase Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a>) <font color=\"red\">-4.9%</font> premarket after Raymond James <a target=\"_blank\" href=\"http://www.streetinsider.com/Hot+Downgrades/UPDATE%3A+Raymond+James+Downgrades+Enphase+Energy+%28ENPH%29+to+Underperform/8213789.html\">downgrades</a> shares to Underperform, noting that after rallying 79%YTD - second only to SunPower (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a>) in the space - the stock is currently at 19x the firm's 2014 CFPS estimate and 145% of its five-year DCF estimate.</p><div class=\"tiny-share-widget\" data-id=\"911991\" data-linked=\"Enphase Energy (NASDAQ:ENPH) -4.9% premarket after Raymond James downgrades shares to...\" data-tweet=\"$ENPH $ENPH $SPWR - Enphase Energy (NASDAQ:ENPH) -4.9% premarket after Raymond James downgrades shares to Underperform, noting that after rallying 79%YTD - second only to SunPower (NASDAQ:SPWR) in the space - the stock is currently at 19x the firm&#39;s 20... https://seekingalpha.com/news/911991?source=tweet\" data-url=\"https://seekingalpha.com/news/911991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911971\" data-ts=\"1364389298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buffalo Wild Wings (BLWD) sees a member of the bear camp wave the white flag as Feltl moves off...</a></h4><p>Buffalo Wild Wings (BLWD) sees a member of the bear camp <a href=\"https://twitter.com/Briefingcom/status/316894438813212672\" target=\"_blank\">wave the white flag</a> as Feltl moves off its Sell rating to give the restaurant operator a more appetizing Hold rating. BWLD <font color=\"green\">+0.6%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"911971\" data-linked=\"Buffalo Wild Wings (BLWD) sees a member of the bear camp wave the white flag as Feltl moves off...\" data-tweet=\"Buffalo Wild Wings (BLWD) sees a member of the bear camp wave the white flag as Feltl moves off its Sell rating to give the restaurant operator a more appetizing Hold rating. BWLD +0.6% premarket. https://seekingalpha.com/news/911971?source=tweet\" data-url=\"https://seekingalpha.com/news/911971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911931\" data-ts=\"1364388718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTP\" target=\"_blank\">CHTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chelsea Therapeutics (NASDAQ:CHTP) shares jump 13.3%, possibly due to SA author Shane Blackman...</a></h4><p>Chelsea Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHTP\" title=\"Chelsea Therapeutics International, Ltd.\">CHTP</a>) shares <font color=\"green\">jump 13.3%</font>, possibly due to SA author Shane Blackman predicting that <a href=\"https://seekingalpha.com/article/1302731-chelsea-therapeutics-a-shoe-in-for-fda-approval-shares-could-double-from-here\" target=\"_blank\">shares could double</a> over the next nine months after the FDA effectively indicated that the company's <a href=\"https://seekingalpha.com/currents/search?query=northera\" target=\"_blank\">Northera drug</a> is a shoe-in for approval in late 2013 or Q1 2014.</p><div class=\"tiny-share-widget\" data-id=\"911931\" data-linked=\"Chelsea Therapeutics (NASDAQ:CHTP) shares jump 13.3%, possibly due to SA author Shane Blackman...\" data-tweet=\"$CHTP - Chelsea Therapeutics (NASDAQ:CHTP) shares jump 13.3%, possibly due to SA author Shane Blackman predicting that shares could double over the next nine months after the FDA effectively indicated that the company&#39;s Northera drug is a shoe-in for ap... https://seekingalpha.com/news/911931?source=tweet\" data-url=\"https://seekingalpha.com/news/911931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911881\" data-ts=\"1364387737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHCI\" target=\"_blank\">CHCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comstock Holding (NASDAQ:CHCI) storms 31% higher after saying yesterday that its Q4 net losses...</a></h4><p>Comstock Holding (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHCI\" title=\"Comstock Homebuilding Companies, Inc.\">CHCI</a>) <font color=\"green\">storms 31% higher</font> after saying yesterday that its <a href=\"http://www.marketwatch.com/story/wednesdays-movers-comstock-cliffs-2013-03-27\" target=\"_blank\">Q4 net losses narrowed</a> to $2M from $2.7M even though revenue dropped to $2.6M from $6.1M. Comstock forecast a full-year profit for 2013, as well as increased home-building revenue and home settlements. \"There is clear and convincing evidence that the housing market has rebounded\" said CEO Christopher Clemente. (PR)</p><div class=\"tiny-share-widget\" data-id=\"911881\" data-linked=\"Comstock Holding (NASDAQ:CHCI) storms 31% higher after saying yesterday that its Q4 net losses...\" data-tweet=\"$CHCI - Comstock Holding (NASDAQ:CHCI) storms 31% higher after saying yesterday that its Q4 net losses narrowed to $2M from $2.7M even though revenue dropped to $2.6M from $6.1M. Comstock forecast a full-year profit for 2013, as well as increased home-b... https://seekingalpha.com/news/911881?source=tweet\" data-url=\"https://seekingalpha.com/news/911881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911871\" data-ts=\"1364387428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRAN\" target=\"_blank\">FRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Francesca&#39;s (NASDAQ:FRAN) announces a secondary offering of 7.394M shares from selling...</a></h4><p>Francesca's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FRAN\" title=\"Francesca's Holdings Corp.\">FRAN</a>) announces a secondary offering of 7.394M shares from selling stockholders. FRAN <font color=\"red\">-5.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"911871\" data-linked=\"Francesca&#39;s (NASDAQ:FRAN) announces a secondary offering of 7.394M shares from selling...\" data-tweet=\"$FRAN - Francesca&#39;s (NASDAQ:FRAN) announces a secondary offering of 7.394M shares from selling stockholders. FRAN -5.5% premarket. https://seekingalpha.com/news/911871?source=tweet\" data-url=\"https://seekingalpha.com/news/911871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911851\" data-ts=\"1364387358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSX\" target=\"_blank\">DSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Shipping (NYSE:DSX) +4.5% premarket, apparently thanks to Jim Cramer&#39;s recommendation. The...</a></h4><p>Diana Shipping (NYSE:<a href=\"https://seekingalpha.com/symbol/DSX\" title=\"Diana Shipping, Inc.\">DSX</a>) <font color=\"green\">+4.5%</font> premarket, apparently thanks to <a target=\"_blank\" href=\"http://www.cnbc.com/id/100593596\">Jim Cramer's recommendation</a>. The dry bulk shipping industry is finally beginning to turn the corner, Cramer says, and once DSX breaks above its current ceiling, the stock could easily hit $14.</p><div class=\"tiny-share-widget\" data-id=\"911851\" data-linked=\"Diana Shipping (NYSE:DSX) +4.5% premarket, apparently thanks to Jim Cramer&#39;s recommendation. The...\" data-tweet=\"$DSX - Diana Shipping (NYSE:DSX) +4.5% premarket, apparently thanks to Jim Cramer&#39;s recommendation. The dry bulk shipping industry is finally beginning to turn the corner, Cramer says, and once DSX breaks above its current ceiling, the stock could easil... https://seekingalpha.com/news/911851?source=tweet\" data-url=\"https://seekingalpha.com/news/911851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911791\" data-ts=\"1364386463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharmaceutical (CPRX +3.9%) receives a recommendation from the Data Monitoring...</a></h4><p>Catalyst Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+3.9%</font>) receives a recommendation from the Data Monitoring Committee (DMC) to continue Phase III trials of the firm's Firdapse treatment for Lambert-Easton Myasthenic Syndrome (LEMS). LEMS is a rare autoimmune disorder characterized by muscle weakness of the limbs, and is often associated with an underlying malignancy. (PR)</p><div class=\"tiny-share-widget\" data-id=\"911791\" data-linked=\"Catalyst Pharmaceutical (CPRX +3.9%) receives a recommendation from the Data Monitoring...\" data-tweet=\"$CPRX - Catalyst Pharmaceutical (CPRX +3.9%) receives a recommendation from the Data Monitoring Committee (DMC) to continue Phase III trials of the firm&#39;s Firdapse treatment for Lambert-Easton Myasthenic Syndrome (LEMS). LEMS is a rare autoimmune disord... https://seekingalpha.com/news/911791?source=tweet\" data-url=\"https://seekingalpha.com/news/911791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911771\" data-ts=\"1364386277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattress Firm is upgraded to Outperform from Market Perform by Raymond James following its...</a></h4><p>Mattress Firm is <a href=\"https://twitter.com/usratings/status/316872170129211392\" target=\"_blank\">upgraded</a> to Outperform from Market Perform by Raymond James following its narrow <a href=\"https://seekingalpha.com/currents/post/910801\" target=\"_blank\">Q4 profit miss</a>. MFRM <font color=\"green\">+3.8%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"911771\" data-linked=\"Mattress Firm is upgraded to Outperform from Market Perform by Raymond James following its...\" data-tweet=\"Mattress Firm is upgraded to Outperform from Market Perform by Raymond James following its narrow Q4 profit miss. MFRM +3.8% premarket. https://seekingalpha.com/news/911771?source=tweet\" data-url=\"https://seekingalpha.com/news/911771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911731\" data-ts=\"1364386005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXE\" target=\"_blank\">FXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The euro&#39;s (NYSEARCA:FXE) continued sharp decline - off &amp;nbsp;nearly 10 big numbers since early...</a></h4>The euro's (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='Invesco CurrencyShares Euro Trust ETF'>FXE</a>) continued sharp decline - off &nbsp;<a href=\"http://finviz.com/forex_charts.ashx?t=EURUSD&amp;tf=d1\" target=\"_blank\">nearly 10 big numbers </a>since early February - has the bears <a href=\"http://online.wsj.com/article/SB10001424127887323466204578384721089580346.html\" target=\"_blank\">feeling their oats</a>. Guggenheim's Scott Minerd - burned badly shorting the common currency in 2011 - says he got short again at $1.34 and sees the euro going to parity with the greenback as the ECB will eventually have to buy up peripheral government debt.<div class=\"tiny-share-widget\" data-id=\"911731\" data-linked=\"The euro&#39;s (NYSEARCA:FXE) continued sharp decline - off &amp;nbsp;nearly 10 big numbers since early...\" data-tweet=\"$FXE $ULE $ERO - The euro&#39;s (NYSEARCA:FXE) continued sharp decline - off &amp;nbsp;nearly 10 big numbers since early February - has the bears feeling their oats. Guggenheim&#39;s Scott Minerd - burned badly shorting the common currency in 2011 - says he got sho... https://seekingalpha.com/news/911731?source=tweet\" data-url=\"https://seekingalpha.com/news/911731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911711\" data-ts=\"1364385775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural Resources (NYSE:CLF) -11.5% premarket after shares are downgraded to Underweight...</a></h4><p>Cliffs Natural Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a>) <font color=\"red\">-11.5%</font> premarket after shares are <a href=\"http://www.streetinsider.com/Downgrades/Morgan+Stanley+Downgrades+Cliffs+Natural+Resources+%28CLF%29+to+Underweight/8213658.html\" target=\"_blank\">downgraded</a> to Underweight with a $14 target price (down from $36) at Morgan Stanley. Credit Suisse cuts its target price to $10 from $30, saying CLF <a target=\"_blank\" href=\"https://twitter.com/thenotablecalls/status/316864299886837761\">needs to raise at least $2.3B</a> to maintain a 2.5x debt/EBITDA ratio. Goldman Sachs' <a href=\"http://www.streetinsider.com/Upgrades/Goldman+Sachs+Removes+Sell+Rating+on+Cliffs+Natural+Resources+%28CLF%29%3B+RiskReward+More+Balanced/8213669.html\" target=\"_blank\">removal of its Sell tag</a> (it's now rated Neutral) isn't providing a lifeline.</p><div class=\"tiny-share-widget\" data-id=\"911711\" data-linked=\"Cliffs Natural Resources (NYSE:CLF) -11.5% premarket after shares are downgraded to Underweight...\" data-tweet=\"$CLF - Cliffs Natural Resources (NYSE:CLF) -11.5% premarket after shares are downgraded to Underweight with a $14 target price (down from $36) at Morgan Stanley. Credit Suisse cuts its target price to $10 from $30, saying CLF needs to raise at least $2.... https://seekingalpha.com/news/911711?source=tweet\" data-url=\"https://seekingalpha.com/news/911711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911461\" data-ts=\"1364379313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">While the FTSE and the pound dropped after the BOE&#39;s statement about the capital shortfall of...</a></h4>While the FTSE and the pound <a href=\"https://seekingalpha.com/currents/post/911451\" target=\"_blank\">dropped</a> after the BOE's statement about the capital shortfall of British banks, Barclays (NYSE:<a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a>) is <font color=\"green\">+1.5%</font> in London, Lloyds (NYSE:<a href='https://seekingalpha.com/symbol/LYG' title='Lloyds Banking Group plc'>LYG</a>) <font color=\"green\">+2.8%</font> and RBS <font color=\"green\">+0.5%</font>. However, HSBC is <font color=\"red\">-0.2%</font>.<div class=\"tiny-share-widget\" data-id=\"911461\" data-linked=\"While the FTSE and the pound dropped after the BOE&#39;s statement about the capital shortfall of...\" data-tweet=\"$BCS $BCS $LYG - While the FTSE and the pound dropped after the BOE&#39;s statement about the capital shortfall of British banks, Barclays (NYSE:BCS) is +1.5% in London, Lloyds (NYSE:LYG) +2.8% and RBS +0.5%. However, HSBC is -0.2%. https://seekingalpha.com/news/911461?source=tweet\" data-url=\"https://seekingalpha.com/news/911461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911451\" data-ts=\"1364378970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSBC\" target=\"_blank\">HSBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Various markets dive after the BOE spells out the continued massive risks to British banks. Half...</a></h4><p>Various markets dive after the BOE <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/911431\">spells out</a> the continued massive risks to British banks. <a target=\"_blank\" href=\"http://www.telegraph.co.uk/finance/newsbysector/banksandfinance/9956281/Band-of-England-orders-British-banks-to-raise-25bn-to-cover-future-losses.html\">Half of the 25B</a> that banks must raise this year has been factored into their capital-raising plans. All in all, major banks and building societies face a 50B reduction in their regulatory capital, although HSBC (HBC) doesn't face a shortfall. FTSE 100 <font color=\"red\">-0.1%</font>, S&amp;P futures <font color=\"red\">-0.2%</font>. (PR)</p><div class=\"tiny-share-widget\" data-id=\"911451\" data-linked=\"Various markets dive after the BOE spells out the continued massive risks to British banks. Half...\" data-tweet=\"$HSBC $BCS $LYG - Various markets dive after the BOE spells out the continued massive risks to British banks. Half of the 25B that banks must raise this year has been factored into their capital-raising plans. All in all, major banks and building socie... https://seekingalpha.com/news/911451?source=tweet\" data-url=\"https://seekingalpha.com/news/911451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911411\" data-ts=\"1364375449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European shares are mostly flat-to-lower while the euro hits a four-month low of $1.28175 as...</a></h4><p>European shares are mostly flat-to-lower while the euro hits a <a href=\"http://www.reuters.com/article/2013/03/27/markets-global-idUSL5N0CJ13020130327\" target=\"_blank\">four-month low</a> of $1.28175 as fears about the longer-term impact of Cyprus's bailout offset positive sentiment from strong U.S. economic data yesterday. EU Stoxx 50 <font color=\"red\">-0.2%</font>, London <font color=\"green\">+0.1%</font>, Paris <font color=\"red\">-0.1%</font>, Frankfurt flat, Milan <font color=\"red\">-0.3%</font>, Madrid <font color=\"red\">-0.8%</font>. Euro <font color=\"red\">-0.2%</font> now at $1.2839.</p><div class=\"tiny-share-widget\" data-id=\"911411\" data-linked=\"European shares are mostly flat-to-lower while the euro hits a four-month low of $1.28175 as...\" data-tweet=\"European shares are mostly flat-to-lower while the euro hits a four-month low of $1.28175 as fears about the longer-term impact of Cyprus&#39;s bailout offset positive sentiment from strong U.S. economic data yesterday. EU Stoxx 50 -0.2%, London +0.1%, Pari... https://seekingalpha.com/news/911411?source=tweet\" data-url=\"https://seekingalpha.com/news/911411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"911331\" data-ts=\"1364369483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/911331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian stocks follow Wall Street higher after strong data for U.S. home prices and durable goods....</a></h4><a href=\"http://www.reuters.com/article/2013/03/27/us-markets-global-idUSBRE88901C20130327\" target=\"_blank\">Asian stocks</a> follow Wall Street higher after strong data for U.S. home prices and durable goods. Japan <font color=\"green\">+0.2%</font>, Hong Kong <font color=\"green\">+0.7%</font>, China <font color=\"green\">+0.3%</font>, India <font color=\"green\">+0.1%</font>.<div class=\"tiny-share-widget\" data-id=\"911331\" data-linked=\"Asian stocks follow Wall Street higher after strong data for U.S. home prices and durable goods....\" data-tweet=\"Asian stocks follow Wall Street higher after strong data for U.S. home prices and durable goods. Japan +0.2%, Hong Kong +0.7%, China +0.3%, India +0.1%. https://seekingalpha.com/news/911331?source=tweet\" data-url=\"https://seekingalpha.com/news/911331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}